78results about How to "Safe and effective use" patented technology

A measuring gauge for measuring the relative position of two bones during surgery, the measuring gauge comprising an anchor, an adapter, an outrigger and a locking joint.

The present invention is directed to a pleated medical device assembly, preferably a pleated stent assembly, comprising a tube co-pleated with a balloon to a delivery width suitable for intraluminal delivery. Because the tube of the present invention transitions between its original diameter and its delivery diameter by folding and unfolding, rather than by radial contraction and expansion, the wall of the tube of the present invention may be substantially non-expandable, and thus may be substantially solid. The pleated stent assembly of the present invention is particularly suited for the treatment of neurovascular aneurysms.

The present invention comprises novel compositions and methods for oral hygiene and for treating and preventing oral disease in humans and in animals. In one embodiment, the novel compositions of the present invention comprise a unique oral hygiene solution that can be added to drinking water. The invention provides compositions and methods for maintaining oral health that are convenient to use and are formulated so that they are safe for regular use by humans and animals.

The invention discloses a communication device, a network device and an alarm method. The communication device includes: an information collecting unit used for collecting simultaneous audio recording and/or image information; a speech recognition unit used for monitoring the field sounds and comparing the field sounds with preset alarm sounds by adopting the sound identifying technique after the field sounds are received, so as to reach an identifying result whether the field sounds are alarm sounds; an alarm trigger unit used for triggering the information collecting unit to work after the speech recognition unit identifies that the field sounds are alarm sounds; and an alarm starting unit used for sending the field sounds and/or image information that are collected by the information collecting unit to a preset location. The invention is capable of increasing the safety and validity of alarming.

A portable winch apparatus having a rechargeable battery and electrical outlets for the charging and operation of external accessory devices. The winch is housed in a casing with various anchor attachments that allow for multiple dragging, towing, and lifting arrangements. Because the winch apparatus incorporates at least one accessory outlet which is powered by the attached rechargeable battery power supply, the present invention combines the portability advantages of hand held winches with the power output options available to vehicle mounted winches. The invention achieves further versatility through incorporation of a wireless remote control unit, and its versatile structural organization around an internal frame that permits it to be manufactured in differing configurations with different geometries.

A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to improve cardiac and/or cardiovascular health. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to control cholesterol levels.

A method for killing malignant brain tumor cells in vivo entails providing replication competent herpes simplex virus vectors to tumor cells. A replication competent herpes simplex virus vector, with defective expression of the γ34.5 gene and the ribonucleotide reductase gene, specifically destroys tumor cells, is hypersensitive to anti-viral agents, and yet is not neurovirulent.

A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be applied to an topical surface and/or an otic surface of an animal (e.g., canine, feline) such that an topical malady and/or otic malady may be inhibited and/or ameliorated.

A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be applied to an oral surface of an animal (e.g., canine, feline) such that an oral malady may be inhibited and/or ameliorated.

The present invention disclosed a liquid acidifier and making method. The present invention comprises organic acids and relevant soluble salts. After the organic acids and the relevant soluble salts are treated by the following procedures of heating, melting, mixing, removing bacteria, filtrating and so on, the liquid acidifier is made. The content of organic acids is over 70percent, which can reduce the pH value of drinking water and intestine, can prevent the harmful flora, can restrain the growth of the salmonella, at the same time can improve the stress ability of the animals, can reduce the death rate and promote the growth rate, and can enhance the absorption rate and conversion of feed. The present invention provides a new idea for developing a compound acidifier.

A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to control fluid and/or waste levels.

Disclosed are specialized flour for nutrition meals for diabetes and a preparation method and use thereof. The flour is based on cereal meal as a basic material and is added to a defatted soybean vegetable protein powder and a soybean tissue isolated dietary fiber power, wherein in the dry flour base, the content of protein is 20-26 weight %, the content of the dietary fiber is 4-10 weight %, the content of carbohydrate is no more than 65 weight %, and the content of fat is no more than 4% of the weight. The method comprises physically mixing the cereal meal, the defatted soybean vegetable protein powder and the soybean tissue isolated dietary fiber power under atmospheric pressure. Food and semi-finished products made from the flour are used for preventing and/or treating diabetes.

The present invention refers to a method of treating a cancerous or non-cancerous skin lesion of a subject, e.g. a human patient, by epidermal radioisotope therapy, a specialized type of brachytherapy, comprising the steps of (a) defining and marking an area of skin to be treated; (b) covering said area with a protective layer, e.g. a protective film or foil; (c) applying a tailor-made radioactive source by applying a layer of a radioactive source material on said protective layer, such that said area is covered by said material while any area not to be treated is spared; and (d) removing the radioactive source after a predetermined time period of irradiation.

A system and method for delivering instructions in an easy-to-understand format designated as “Show and Tell”—Tech (ST-Tech) Format. For people who cannot read and understand medications or health instructions, ST-Tech offers useful, effective and safety features based on color code, pictures, voice and icons to help ensure accuracy in the management or administration of medications. Just as some icons or signs have been made and became part of the rules of the road universally, this electronic “Show and Tell” electronic method is intended to simplify for the navigation through multiple medication regimens. Medical prescription processed into ST-Tech Format become conversions of the text entries of these prescriptions into visual and spoken instructions for the patients. ST-Tech will help millions of patients struggling with low health literacy and numeracy. Apart from medical prescriptions, the ST-Tech Formatting principle can also be useful in other medical or non-medical scheduled events or tasks.

The invention relates to a method for controlling heavy metal pollution and optimization and utilization of compost by adopting the compost grain size of screening household garbage. The invention is characterized in that: the household garbage is pretreated, and then the garbage compost is screened by adopting the standard screens of more than 1.6 mm, 1.6 to 0.8mm, 0.8 to 0.4mm, 0.4 to 0.2mm, 0.2 to 0.1mm or less than 0.1 mm, so that the garbage compost in different sizes can be collected; the organic matter, trace element and heavy metal content are measured, and which can be used in the soil in different production targets according to needs. The invention can reach the purposes on removing excessive heavy metal hazardous substance in the compost and reserving the compost grain for providing nutrients for the plant growth and improving the physicochemical property, and the invention also can provide scientific basis for using the household garbage safely, effectively and reasonably.

The present disclosure describes the use of genetic variance information for folate transport or metabolism genes or pyrimidine transport or metabolism genes in the selection of effective methods of treatment of a disease or condition. The variance information is indicative of the expected response of a patient to a method of treatment. Methods of determining relevant variance information and additional methods of using such variance information are also described.